TVTX | | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Apr 11, 2024 | Sale | $6.74 | 54 | 364 | 70,849 | Apr 12, 2024, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | Feb 01, 2024 | Sale | $8.70 | 19,122 | 166,435 | 360,616 | Feb 02, 2024, 04:06 PM |
TVTX | | Travere Therapeutics, Inc. | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | Feb 01, 2024 | Sale | $8.71 | 4,764 | 41,495 | 83,310 | Feb 02, 2024, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Feb 01, 2024 | Sale | $8.53 | 2,820 | 24,058 | 52,017 | Feb 02, 2024, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | Jan 23, 2024 | Sale | $8.96 | 2,062 | 18,476 | 56,034 | Jan 25, 2024, 04:10 PM |
TVTX | | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | Jan 23, 2024 | Sale | $8.96 | 7,873 | 70,542 | 234,722 | Jan 25, 2024, 04:10 PM |
TVTX | | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Jan 23, 2024 | Sale | $9.07 | 853 | 7,735 | 49,721 | Jan 25, 2024, 04:10 PM |
TVTX | | Travere Therapeutics, Inc. | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | Jan 23, 2024 | Sale | $8.96 | 2,062 | 18,476 | 60,484 | Jan 25, 2024, 04:10 PM |
TVTX | | Travere Therapeutics, Inc. | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Jan 23, 2024 | Sale | $9.07 | 910 | 8,252 | 41,337 | Jan 25, 2024, 04:10 PM |
TVTX | | Travere Therapeutics, Inc. | Heerma Peter | CHIEF COMMERCIAL OFFICER | Jan 23, 2024 | Sale | $9.07 | 1,559 | 14,138 | 78,698 | Jan 25, 2024, 04:10 PM |
TVTX | | Travere Therapeutics, Inc. | Inrig Jula | Chief Medical Officer | Jan 04, 2024 | Sale | $9.17 | 440 | 4,035 | 35,248 | Jan 05, 2024, 04:11 PM |
TVTX | | Travere Therapeutics, Inc. | Inrig Jula | Chief Medical Officer | Jan 03, 2024 | Sale | $9.48 | 2,069 | 19,613 | 35,688 | Jan 05, 2024, 04:11 PM |
TVTX | | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Oct 03, 2023 | Sale | $8.25 | 3,091 | 25,504 | 80,257 | Oct 04, 2023, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | Sep 05, 2023 | Sale | $14.71 | 457 | 6,723 | 50,574 | Sep 05, 2023, 08:15 PM |
TVTX | | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | Sep 05, 2023 | Sale | $14.71 | 1,815 | 26,699 | 61,173 | Sep 05, 2023, 08:13 PM |
TVTX | | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | Sep 05, 2023 | Sale | $14.71 | 1,815 | 26,699 | 58,096 | Sep 05, 2023, 08:12 PM |
TVTX | | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Sep 05, 2023 | Sale | $14.71 | 4,455 | 65,533 | 242,595 | Sep 05, 2023, 08:10 PM |
TVTX | | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | May 10, 2023 | Sale | $16.59 | 455 | 7,548 | 51,031 | May 12, 2023, 04:14 PM |
TVTX | | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | May 10, 2023 | Sale | $16.59 | 825 | 13,687 | 56,611 | May 12, 2023, 04:11 PM |
TVTX | | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | May 10, 2023 | Sale | $16.59 | 825 | 13,687 | 59,211 | May 12, 2023, 04:09 PM |
TVTX | | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | May 11, 2023 | Sale | $16.12 | 122 | 1,967 | 42,247 | May 12, 2023, 04:06 PM |
TVTX | | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | May 10, 2023 | Sale | $16.59 | 436 | 7,233 | 42,369 | May 12, 2023, 04:06 PM |
TVTX | | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | Apr 11, 2023 | Sale | $21.49 | 47 | 1,010 | 51,486 | Apr 13, 2023, 04:07 PM |
TVTX | | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | Feb 01, 2023 | Sale | $22.25 | 2,590 | 57,628 | 57,436 | Feb 02, 2023, 07:11 PM |
TVTX | | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | Feb 01, 2023 | Sale | $22.25 | 2,590 | 57,628 | 60,036 | Feb 02, 2023, 07:08 PM |
TVTX | | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Feb 01, 2023 | Sale | $21.75 | 1,779 | 38,697 | 82,069 | Feb 02, 2023, 07:04 PM |
TVTX | | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | Feb 01, 2023 | Sale | $21.75 | 1,588 | 34,542 | 51,533 | Feb 02, 2023, 07:02 PM |
TVTX | | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Feb 01, 2023 | Sale | $22.25 | 8,196 | 182,361 | 237,150 | Feb 02, 2023, 06:58 PM |
TVTX | | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | Feb 01, 2023 | Sale | $21.75 | 1,671 | 36,348 | 43,165 | Feb 02, 2023, 06:53 PM |
TVTX | | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | Feb 02, 2023 | Sale | $22.42 | 360 | 8,071 | 42,805 | Feb 02, 2023, 06:53 PM |
TVTX | | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | Jan 24, 2023 | Sale | $21.90 | 905 | 19,823 | 35,028 | Jan 26, 2023, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | Jan 25, 2023 | Sale | $21.63 | 192 | 4,153 | 34,836 | Jan 26, 2023, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | Jan 24, 2023 | Sale | $21.50 | 2,062 | 44,333 | 42,376 | Jan 26, 2023, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 24, 2023 | Sale | $21.50 | 2,062 | 44,333 | 39,776 | Jan 26, 2023, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Jan 24, 2023 | Sale | $21.50 | 6,442 | 138,503 | 147,846 | Jan 26, 2023, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | Jan 24, 2023 | Sale | $21.90 | 852 | 18,663 | 32,871 | Jan 26, 2023, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Jan 24, 2023 | Sale | $21.90 | 1,550 | 33,952 | 63,598 | Jan 26, 2023, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Jan 05, 2023 | Sale | $20.75 | 5,625 | 116,719 | 154,288 | Jan 06, 2023, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | Inrig Jula | Chief Medical Officer | Jan 04, 2023 | Sale | $20.75 | 2,051 | 42,558 | 17,949 | Jan 06, 2023, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | Inrig Jula | Chief Medical Officer | Jan 05, 2023 | Sale | $20.75 | 442 | 9,172 | 17,507 | Jan 06, 2023, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Oct 04, 2022 | Sale | $25.68 | 3,042 | 78,119 | 65,148 | Oct 06, 2022, 08:10 PM |
TVTX | | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | Sep 13, 2022 | Sale | $28.00 | 349 | 9,772 | 35,933 | Sep 15, 2022, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | May 11, 2022 | Sale | $21.71 | 1,563 | 33,940 | 44,485 | May 12, 2022, 08:49 PM |
TVTX | | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | May 10, 2022 | Sale | $21.51 | 900 | 19,359 | 42,888 | May 12, 2022, 08:47 PM |
TVTX | | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | May 12, 2022 | Sale | $21.51 | 1,050 | 22,584 | 41,838 | May 12, 2022, 08:47 PM |
TVTX | | Travere Therapeutics, Inc. | Clague Laura | Chief Financial Officer | May 10, 2022 | Sale | $21.51 | 825 | 17,746 | 37,030 | May 12, 2022, 08:45 PM |
TVTX | | Travere Therapeutics, Inc. | Clague Laura | Chief Financial Officer | May 11, 2022 | Sale | $21.51 | 1,375 | 29,576 | 35,655 | May 12, 2022, 08:45 PM |
TVTX | | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | May 10, 2022 | Sale | $21.51 | 436 | 9,378 | 36,178 | May 12, 2022, 08:44 PM |
TVTX | | Travere Therapeutics, Inc. | Calvin Sandra | SVP, Chief Accounting Officer | May 11, 2022 | Sale | $21.92 | 445 | 9,756 | 35,733 | May 12, 2022, 08:44 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | May 11, 2022 | Sale | $21.92 | 2,575 | 56,457 | 146,919 | May 12, 2022, 08:35 PM |
TVTX | | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Feb 10, 2022 | Sale | $27.84 | 4,832 | 134,523 | 159,913 | Feb 11, 2022, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | Calvin Sandra | VP, Corp Controller and CAO | Jan 31, 2022 | Sale | $26.51 | 798 | 21,152 | 36,614 | Feb 02, 2022, 04:22 PM |
TVTX | | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 31, 2022 | Sale | $27.40 | 1,350 | 36,990 | 43,788 | Feb 02, 2022, 04:20 PM |
TVTX | | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | Jan 31, 2022 | Sale | $27.40 | 1,125 | 30,825 | 45,235 | Feb 02, 2022, 04:19 PM |
TVTX | | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Jan 31, 2022 | Sale | $27.40 | 1,125 | 30,825 | 67,297 | Feb 02, 2022, 04:18 PM |
TVTX | | Travere Therapeutics, Inc. | Clague Laura | Chief Financial Officer | Jan 31, 2022 | Sale | $27.40 | 1,238 | 33,921 | 37,855 | Feb 02, 2022, 04:17 PM |
TVTX | | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Jan 31, 2022 | Sale | $27.40 | 4,813 | 131,876 | 164,745 | Feb 02, 2022, 04:16 PM |
TVTX | | Travere Therapeutics, Inc. | Calvin Sandra | VP, Corp Controller and CAO | Jan 24, 2022 | Sale | $24.58 | 934 | 22,955 | 28,662 | Jan 26, 2022, 04:38 PM |
TVTX | | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | Jan 24, 2022 | Sale | $24.98 | 1,875 | 46,837 | 36,520 | Jan 26, 2022, 04:37 PM |
TVTX | | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Jan 24, 2022 | Sale | $24.98 | 1,875 | 46,837 | 58,582 | Jan 26, 2022, 04:36 PM |
TVTX | | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 24, 2022 | Sale | $24.98 | 2,250 | 56,205 | 35,298 | Jan 26, 2022, 04:35 PM |
TVTX | | Travere Therapeutics, Inc. | Clague Laura | Chief Financial Officer | Jan 24, 2022 | Sale | $24.98 | 2,063 | 51,534 | 29,253 | Jan 26, 2022, 04:34 PM |
TVTX | | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Jan 24, 2022 | Sale | $24.98 | 7,873 | 196,668 | 131,710 | Jan 26, 2022, 04:33 PM |
TVTX | | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | Jan 11, 2022 | Sale | $27.40 | 5,000 | 137,000 | 37,548 | Jan 12, 2022, 04:07 PM |
TVTX | | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | Jan 11, 2022 | Sale | $27.40 | 2,500 | 68,500 | 38,395 | Jan 12, 2022, 04:06 PM |
TVTX | | Travere Therapeutics, Inc. | Clague Laura | Chief Financial Officer | Jan 11, 2022 | Sale | $27.40 | 7,500 | 205,500 | 31,316 | Jan 12, 2022, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Jan 04, 2022 | Sale | $30.43 | 4,832 | 147,038 | 152,083 | Jan 06, 2022, 04:03 PM |
TVTX | | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Jan 05, 2022 | Sale | $29.95 | 12,500 | 374,369 | 141,722 | Jan 06, 2022, 04:03 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | Nov 16, 2021 | Sale | $29.39 | 31,800 | 934,602 | 149,494 | Nov 18, 2021, 04:08 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | Nov 05, 2021 | Sale | $21.23 | 20,000 | 424,600 | 171,794 | Nov 09, 2021, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | Nov 01, 2021 | Sale | $29.48 | 5,000 | 147,400 | 23,000 | Nov 03, 2021, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | Nov 02, 2021 | Sale | $30.00 | 3,500 | 105,000 | 19,500 | Nov 03, 2021, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | Oct 07, 2021 | Sale | $21.24 | 120,000 | 2,548,560 | 249,794 | Oct 08, 2021, 04:18 PM |
TVTX | | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Oct 04, 2021 | Sale | $24.77 | 3,058 | 75,746 | 60,457 | Oct 05, 2021, 04:06 PM |
TVTX | | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Aug 17, 2021 | Sale | $17.12 | 1,407 | 24,086 | 63,515 | Aug 17, 2021, 07:41 PM |
TVTX | | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Aug 17, 2021 | Sale | $17.12 | 7,836 | 134,142 | 156,915 | Aug 17, 2021, 07:40 PM |
TVTX | | Travere Therapeutics, Inc. | Rosenberg Noah L. | Chief Medical Officer | Aug 17, 2021 | Sale | $17.12 | 1,407 | 24,085 | 47,614 | Aug 17, 2021, 07:39 PM |
TVTX | | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | Aug 17, 2021 | Sale | $17.12 | 1,407 | 24,085 | 35,731 | Aug 17, 2021, 07:38 PM |
TVTX | | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | Aug 17, 2021 | Sale | $17.12 | 1,407 | 24,086 | 37,548 | Aug 17, 2021, 07:35 PM |
TVTX | | Travere Therapeutics, Inc. | Clague Laura | Chief Financial Officer | Aug 17, 2021 | Sale | $17.12 | 1,407 | 24,085 | 31,316 | Aug 17, 2021, 07:34 PM |
TVTX | | Travere Therapeutics, Inc. | Rosenberg Noah L. | Chief Medical Officer | Jul 28, 2021 | Sale | $13.81 | 1,250 | 17,263 | 44,521 | Jul 29, 2021, 04:09 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | Apr 16, 2021 | Sale | $21.23 | 20,000 | 424,600 | 198,940 | Apr 20, 2021, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | ASELAGE STEVE | Director | Mar 17, 2021 | Sale | $23.40 | 27,727 | 648,756 | 206,667 | Mar 19, 2021, 04:05 PM |
TVTX | | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | Feb 17, 2021 | Sale | $27.35 | 1,250 | 34,188 | 36,082 | Feb 18, 2021, 06:26 PM |
TVTX | | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | Feb 18, 2021 | Sale | $28.67 | 1,250 | 35,838 | 34,832 | Feb 18, 2021, 06:26 PM |
TVTX | | Travere Therapeutics, Inc. | Rosenberg Noah L. | Chief Medical Officer | Feb 05, 2021 | Sale | $31.41 | 1,125 | 35,336 | 47,469 | Feb 09, 2021, 04:32 PM |
TVTX | | Travere Therapeutics, Inc. | Rosenberg Noah L. | Chief Medical Officer | Feb 08, 2021 | Sale | $31.58 | 1,125 | 35,527 | 46,344 | Feb 09, 2021, 04:32 PM |
TVTX | | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Feb 05, 2021 | Sale | $31.41 | 1,125 | 35,336 | 60,469 | Feb 09, 2021, 04:31 PM |
TVTX | | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Feb 08, 2021 | Sale | $31.58 | 1,125 | 35,527 | 59,344 | Feb 09, 2021, 04:31 PM |
TVTX | | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | Feb 05, 2021 | Sale | $31.41 | 2,250 | 70,672 | 39,582 | Feb 09, 2021, 04:30 PM |
TVTX | | Travere Therapeutics, Inc. | ROTE WILLIAM E. | Senior Vice President, R&D | Feb 08, 2021 | Sale | $31.58 | 2,250 | 71,055 | 37,332 | Feb 09, 2021, 04:30 PM |
TVTX | | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | Feb 05, 2021 | Sale | $31.41 | 2,250 | 70,672 | 39,955 | Feb 09, 2021, 04:30 PM |
TVTX | | Travere Therapeutics, Inc. | REED ELIZABETH E | SVP, GC & Corporate Secretary | Feb 08, 2021 | Sale | $31.58 | 2,250 | 71,055 | 37,705 | Feb 09, 2021, 04:30 PM |
TVTX | | Travere Therapeutics, Inc. | Clague Laura | Chief Financial Officer | Feb 05, 2021 | Sale | $31.41 | 2,250 | 70,672 | 34,473 | Feb 09, 2021, 04:29 PM |
TVTX | | Travere Therapeutics, Inc. | Clague Laura | Chief Financial Officer | Feb 08, 2021 | Sale | $31.58 | 2,250 | 71,055 | 32,223 | Feb 09, 2021, 04:29 PM |
TVTX | | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Feb 05, 2021 | Sale | $31.41 | 4,813 | 151,176 | 161,626 | Feb 09, 2021, 04:28 PM |
TVTX | | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Feb 08, 2021 | Sale | $31.58 | 4,813 | 151,995 | 156,813 | Feb 09, 2021, 04:28 PM |
TVTX | | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Feb 02, 2021 | Sale | $30.75 | 563 | 17,312 | 57,657 | Feb 03, 2021, 09:33 PM |
TVTX | | Travere Therapeutics, Inc. | Heerma Peter | Chief Commercial Officer | Feb 03, 2021 | Sale | $28.91 | 563 | 16,276 | 57,094 | Feb 03, 2021, 09:33 PM |
TVTX | | Travere Therapeutics, Inc. | Rosenberg Noah L. | Chief Medical Officer | Feb 03, 2021 | Sale | $28.91 | 1,813 | 52,414 | 44,657 | Feb 03, 2021, 09:33 PM |